EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Eur J Cardiothorac Surg 2009;35:922-923. doi:10.1016/j.ejcts.2009.02.009
Copyright © 2009, European Association for Cardio-thoracic Surgery. Published by Elsevier. All rights reserved.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Thorsten Hanke
Martin Misfeld
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hanke, T.
Right arrow Articles by Sievers, H.-H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hanke, T.
Right arrow Articles by Sievers, H.-H.
Related Collections
Right arrow Cardiac - other
Right arrow Electrophysiology - arrhythmias


Letters to the Editor

Re: Prospective randomized comparison of left atrial and biatrial radiofrequency ablation in the treatment of atrial fibrillation

Thorsten Hanke*, Martin Misfeld, Ulrich Stierle, Hans-H. Sievers

Clinic for Cardiac and Thoracic Vascular Surgery, University of Lübeck, Lübeck, Germany

Received 11 January 2009; accepted 6 February 2009.

* Corresponding author. Address: University of Lübeck, Department of Cardiac and Thoracic Vascular Surgery, Ratzeburger Allee 160, 23538 Lübeck, Germany. Tel.: +49 451 500 2108; fax: +49 451 500 2051. (Email: thorstenhanke{at}yahoo.com).

Key Words: Atrial fibrillation • Surgical therapy • Nomenclature • Heart rhythm documentation • Follow-up

We read the article by Wang et al. [1] with great interest. In our opinion, a few points ought to be addressed.

The authors describe two different surgical techniques for surgical atrial fibrillation ablation therapy, the left atrial and the biatrial ablation approach; the LA approach requiring cavotricuspid isthmus ablation in the RA in order to achieve bidirectional block. For better understanding of the well conducted study it would have been of some help if the authors would have mentioned the rationale for performing an atrial ablation line on the right atrial side which in accordance to the guidelines is only recommended in patients with a history of typical atrial flutter or inducible cavotricuspid dependent atrial flutter [2]. The authors also do not explain why the additional opening of the right atrium is regarded as ‘left’ sided. In accordance with others [3] we believe that standardization of ablation therapies is of great help for better understanding, since this is of utmost importance for further scientific comparison of different ablation strategies. By calling a two sided ablation therapy a one sided therapy, confusion might arise. In addition, it is beneficial to use a common nomenclature when reporting on ablation issues [2]. The term ‘permanent’ atrial fibrillation describes that group of patients where a decision has been made not to pursue restoration of sinus rhythm by any means, thus the term ‘longstanding persistent’ would have been appropriate for the patients being studied. Furthermore, there is a need for specification when defining the kind of surgical ablation technique; the term ‘Maze procedure’, as stated by Ad [4], should only be used to describe the procedure as it was developed by Cox et al.

The authors well describe the patients’ heart rhythm status and AF recurrence in the early postoperative period. However, a high incidence of atrial fibrillation recurrence (35–40%) due to inflammation occurs within the first three months after ablation and is not related to long-term success. Therefore, in order to avoid confusion, this time period ought to be omitted in the outcome analysis of ablation therapy [2]. For further evaluation of post-ablation heart rhythm, and this is regarded as a ‘minimal monitoring strategy’, regular intervals of 24 h Holter monitoring (24 HM) for one to two years are strongly recommended [2]. In case of ‘rhythm at last follow-up’, an overestimation of procedural success is inevitable. There is an agreement that the most appropriate heart rhythm documentation after ablation therapy is accomplished when using continuous rhythm surveillance as achieved with implantable devices [2]. We were able to show that the sensitivity of quarterly performed 24 HM after surgical ablation therapy reaches only 60% with a negative predictive value of 64% when intraindividually compared to continuous heart rhythm monitoring [5]. Thus, in our opinion, for further more ‘real life’ reports after ablation therapy and thus gaining more certainty about the procedural success, long-term continuous rhythm surveillance as well as usage of a defined nomenclature might be of an additional benefit.

References

  1. Wang J, Meng X, Li H, Cui Y, Han J, Xu C. Prospective randomized comparison of left atrial and biatrial radiofrequency ablation in the treatment of atrial fibrillation. Eur J Cardiothorac Surg 2009;35:116-122.[Abstract/Free Full Text]
  2. Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, Crijns HJ, Damiano Jr. RJ, Davies DW, Haines DE, Haissaguerre M, Iesaka Y, Jackman W, Jais P, Kottkamp H, Kuck KH, Lindsay BD, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Natale A, Pappone C, Prystowsky E, Raviele A, Ruskin JN, Shemin RJ. HRS/EHRA/ECAS Expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 2007;4:816-861.[CrossRef][Medline]
  3. Ad N. The surgical treatment for atrial fibrillation: a call for standardization. J Thorac Cardiovasc Surg 2008;135:727-728.[Free Full Text]
  4. Ad N. How do we spell maze? A dialogue concerning definitions and goals. J Thorac Cardiovasc Surg 2006;132:1253-1255.[Free Full Text]
  5. Hanke T, Karlub A, Charitos E, Hagemann A, Graf B, Stierle U, Sievers H-H. New insights into surgical atrial fibrillation ablation therapy: initial experience with a novel permanently implantable heart rhythm monitor device. Circulation 2008;118:S864.



This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
J. Wang and X. Meng
Reply to Hanke et al.
Eur. J. Cardiothorac. Surg., May 1, 2009; 35(5): 923 - 924.
[Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Thorsten Hanke
Martin Misfeld
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hanke, T.
Right arrow Articles by Sievers, H.-H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hanke, T.
Right arrow Articles by Sievers, H.-H.
Related Collections
Right arrow Cardiac - other
Right arrow Electrophysiology - arrhythmias


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS